Jon Kessler Acquires Shares in Phreesia, Inc.

Jon Kessler, an insider at Phreesia, Inc. (NYSE:PHR), purchased 19,290 shares of the company on June 24, 2026. The shares were bought at an average price of $9.59, bringing the total transaction value to approximately $184,991. This purchase was not part of a pre-planned trading program.

Other Institutional Activity in Phreesia, Inc.

Several institutional investors have recently adjusted their holdings in Phreesia, Inc. Pale Fire Capital SE opened a new position with 8,649,329 shares valued at about $72.48 million. BlackRock, Inc. increased its stake by 284,445 shares to a total of 5,920,469 shares, worth roughly $49.61 million, marking a 5% increase. Vanguard Portfolio Management LLC also initiated a new position, buying 3,335,121 shares valued at approximately $27.95 million. AQR Capital Management LLC significantly boosted its holdings by 1,415,465 shares, a 323.8% increase, ending with 1,852,559 shares valued at around $15.52 million.

Phreesia, Inc. Stock Down 24.9%

Shares of Phreesia, Inc. traded near $9.13 on Saturday. The company, with a market cap of $622.4 million, has a P/E ratio of 62.94 and a forward P/E of 6.27. Its beta is 0.884, indicating less volatility compared to the market. The stock's 52-week range spans from a low of $7.77 to a high of $32.76. It has a 50-day moving average of $9.38 and a 200-day moving average of $15.21. Phreesia maintains a current ratio of 1.76 and a quick ratio of 1.43, with a debt-to-equity ratio of 25.78.

Recent Earnings

In its latest financial results, Phreesia, Inc. reported revenue of $495.59 million, reflecting a growth rate of 12.9%. The company achieved an EPS of $0.16, with a net margin of 1.85% and a return on equity of 2.86%. The next earnings report is expected on September 3, 2026.

Insider Buying and Selling at Phreesia, Inc.

On June 24, 2026, several insiders, including Jon Kessler, Lainie Goldstein, Mark Douglas Smith, Ramin Sayar, and Gillian Munson, each purchased 19,290 shares at $9.59 per share. Additionally, Lisa Egbuonu-Davis sold 2,546 shares on June 25, 2026, at $9.53 per share under a planned trading program.

Analysts Set New Price Targets

On May 29, 2026, Truist Securities maintained its hold rating on Phreesia with a $12 price target. Citigroup also maintained a hold rating with the same target. Canaccord Genuity and DA Davidson both maintained buy ratings, with targets of $16 and $14, respectively, on May 28, 2026. The consensus among analysts is a buy rating, with a mean price target of $13.94 based on 17 analyst opinions.

About Phreesia, Inc.

Phreesia, Inc. offers a software platform for healthcare providers in the U.S. and Canada. Its solutions include appointment optimization, patient communication, and integrated payment systems. The company also provides digital intake and data capture tools. Based in Wilmington, Delaware, Phreesia serves various healthcare organizations, including hospitals and ambulatory practices.

Bottom Line

Jon Kessler's recent stock purchase reflects ongoing interest in Phreesia, Inc. by insiders. Investors often track such insider activity for potential insights into company performance. Phreesia's recent earnings and institutional interest suggest it remains a focus for market watchers. As always, remember that these reports reflect past transactions and may not indicate future performance.